Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma

Osteosarcoma (OS) is the most common bone cancer, mainly diagnosed in children and adolescents. So far, no reliable molecular biomarkers have been identified to effectively evaluate OS prognosis and immune infiltration. Herein, we curated transcriptome profiles and clinical information from the publ...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qinghua, Zhang, Wenjing, Guo, Yuxian, Li, Yuting, Fu, Kaifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610143/
https://www.ncbi.nlm.nih.gov/pubmed/34747719
http://dx.doi.org/10.18632/aging.203671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610143/
https://www.ncbi.nlm.nih.gov/pubmed/34747719
http://dx.doi.org/10.18632/aging.203671

Ejemplares similares